ArticleWorld journal of urology2025
Acute kidney injury (AKI) and end stage kidney disease (ESKD) in CKD patients undergoing partial or radical nephrectomy for renal cancer: are we ready to unravel the uncertainty and create new hope?
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Effect of Dexmedetomidine on Postoperative Acute Kidney Injury in High-Risk Partial Nephrectomy Patients: A Retrospective Cohort Study.Drug design, development and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivePatients with moderate to severe preoperative chronic kidney disease (CKD) are often considered at high risk for postoperative acute kidney injury (AKI) and progression to end-stage kidney disease (ESKD), especially when radical nephrectomy (RN) is required. This study evaluated the impact of preoperative CKD on AKI and ESKD risk in patients undergoing RN or partial nephrectomy (PN) for localized renal masses.
methodsWe retrospectively analyzed 1,194 patients with cT1-2 cN0 cM0 renal masses treated at a tertiary center. CKD was staged using KDIGO 2024 guidelines; eGFR was calculated with the 2021 CKD-EPI formula. Postoperative AKI and ESKD were defined per KDIGO 2024. Logistic regression adjusted for age, comorbidity (Charlson Comorbidity Index), tumor size, and surgery type was performed.
resultsOverall, 8.9% had CKD stage 3b-4. AKI occurred in 19.9%, and ESKD in 2.3%. PN reduced AKI risk (aOR 0.19, p < 0.001) but did not significantly reduce ESKD risk (p = 0.550). Advanced CKD was associated with higher ESKD rates (9.4% vs. 1.7%, p < 0.001) and more complications. However, many stage 3b-4 patients did not develop severe AKI or ESKD. Age and comorbidity were strong predictors of adverse outcomes. Older age and higher comorbidity scores further heightened the likelihood of adverse renal outcomes.
conclusionsPreoperative CKD increases the risk of AKI and ESKD, especially with RN. PN lowers AKI risk but does not eliminate long-term decline. Despite expectations, many high-risk patients maintain better-than-expected renal outcomes. These findings support personalized surgical decisions and reinforce the need for nephrology involvement in perioperative care. In this study, we examined kidney outcomes after surgery for kidney cancer in patients with chronic kidney disease. We found that partial nephrectomy reduced the risk of short-term kidney injury. Importantly, many high-risk patients did not require dialysis after surgery.
Indexed as
Identifiers
41148359What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.